← back to search

Frank Kee

Queens University · GB
Area of research
Public Health, Environmental and Occupational Health · Health
Research interest
Research interests include Health disparities and outcomes, Physical Activity and Health, Nutritional Studies and Diet, and Obesity, Physical Activity, Diet.
h-index
88
citations
39,810
works
880
NIH funding
primary concept
email

Recent publications

Investigating Variation in Adherence to Classroom Norms for Smoking and Vaping According to Individual Norms Sensitivities for Adolescents in Northern Ireland and Bogotá
SSRN Electronic Journal 2025cited by 2position: middledoi
Mediation Analysis Investigating the Mechanisms of Two School-Based Smoking Prevention Interventions in Adolescents from Northern Ireland and Bogotá
SSRN Electronic Journal 2025cited by 1position: middledoi
Prognostic Value of Cardiovascular Biomarkers in the Population
JAMA 2024cited by 97position: middledoi
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales
The Lancet 2024cited by 63position: middledoi
Effectiveness and cost-effectiveness of a 12-month automated text message intervention for weight management in postpartum women with overweight or obesity: protocol for the Supporting MumS (SMS) multisite, parallel-group, randomised controlled trial
BMJ Open 2024cited by 4position: middledoi
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus
European Journal of Preventive Cardiology 2023cited by 13position: middledoi
Drinking alcohol in moderation is associated with lower rate of all-cause mortality in individuals with higher rather than lower educational level: findings from the MORGAM project
European Journal of Epidemiology 2023cited by 13position: middledoi
Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries
European Journal of Preventive Cardiology 2023cited by 12position: middledoi
Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination
npj Vaccines 2023cited by 8position: middledoi
How Do Adolescent Smoking Prevention Interventions Work in Different Contextual Settings? A Qualitative Comparative Study Between the UK and Colombia
International Journal of Behavioral Medicine 2023cited by 8position: middledoi
An external validation of the QCOVID3 risk prediction algorithm for risk of hospitalisation and death from COVID-19: An observational, prospective cohort study of 1.66m vaccinated adults in Wales, UK
PLoS ONE 2023cited by 3position: middledoi
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
BMJ 2022cited by 112position: middledoi
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
BMC Medicine 2022cited by 42position: middledoi
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
Vaccines 2022cited by 33position: middledoi
The Role of Epigenetic Clocks in Explaining Educational Inequalities in Mortality: A Multicohort Study and Meta-analysis
The Journals of Gerontology Series A 2022cited by 29position: middledoi
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)
Thorax 2022cited by 20position: middledoi
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)
The Lancet Regional Health - Europe 2022cited by 18position: middledoi
Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK)
International Journal of Epidemiology 2022cited by 14position: middledoi
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT1262b2 and after booster vaccination with BNT1262b2 or mRNA-1273: a population-based cohort study (COVIDENCE UK)
medRxiv 2022cited by 11position: middledoi
Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK)
medRxiv 2022cited by 11position: middledoi
Vitamin D Supplements for Prevention of COVID-19 or other Acute Respiratory Infections: a Phase 3 Randomised Controlled Trial (CORONAVIT)
medRxiv 2022cited by 8position: middledoi
Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project
Preventive Medicine Reports 2022cited by 6position: middledoi
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
medRxiv 2022cited by 6position: middledoi
Determinants of Antibody Responses to Two Doses of ChAdOx1 nCoV-19 or Bnt162b2 and a Subsequent Booster Dose of BNT162b2 or mRNA-1273: Population-Based Cohort Study (COVIDENCE UK)
SSRN Electronic Journal 2022cited by 4position: middledoi
Common protocol for validation of the QCOVID algorithm across the four UK nations
BMJ Open 2022cited by 3position: middledoi
Incidence, determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination: a population-based longitudinal study (COVIDENCE UK)
Research Square 2022cited by 3position: middledoi
Adapting interventions to new contexts—the ADAPT guidance
BMJ 2021cited by 497position: middledoi
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
BMJ 2021cited by 327position: middledoi
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)
Thorax 2021cited by 77position: middledoi
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population‐based study
Addiction 2021cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ronan A Lyons · Swansea University20 papers (2020–2023)Aziz Sheikh · National Institute of Technology Srinagar20 papers (2020–2023)Gwyneth A. Davies · University of Edinburgh15 papers (2021–2023)David A. Jolliffe · Queen Mary University of London15 papers (2021–2023) · 15 papers (2021–2023)Adrian R. Martineau · Queen Mary University of London15 papers (2021–2023) · 15 papers (2021–2023)Mohammad Talaei · National University of Singapore15 papers (2021–2023) · 15 papers (2021–2023)Chris Griffiths · Queen Mary University of London14 papers (2021–2023)Matthew Greenig · University of Cambridge10 papers (2021–2023)Sian Faustini · Institute of Immunology10 papers (2021–2023) · 10 papers (2021–2022)Alex Richter · University of Birmingham9 papers (2021–2023) · 8 papers (2021–2022)Hermann Brenner · Stanford University8 papers (2014–2021) · 8 papers (2021–2022)Paolo Boffetta · Community Cancer Center8 papers (2014–2021) · 8 papers (2022–2022) · 7 papers (2013–2017)